NCT01942551View on ClinicalTrials.gov

Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Benign Prostate Hyperplasia
Interventions
DRUG

Tadalafil

DRUG

Dutasteride

Trial Locations (1)

301-721

Chungnam National University Hospital, Daejeon

Sponsors
All Listed Sponsors
lead

Dongkook Pharmaceutical Co., Ltd.

INDUSTRY